Table 3.
Staging Model A (Berk et al, 2007(15)) | Staging Model B (Kapczinski et al, 2009(19)) | Total | |||||
---|---|---|---|---|---|---|---|
Latent | Stage I | Stage II | Stage III | Stage IV | |||
At risk | Full recovery | Inter‐episodic symptoms | Inter‐episodic Impairment | Inability living autonomously | |||
Stage 0 | Increased risk | 0 | 0 | 0 | 0 | 0 | 0 |
Stage 1 | Nonspecific | 0 | 0 | 0 | 0 | 0 | 0 |
Stage 2 | Threshold episode | 0 | 0 | 4 | 2 | 0 | 6 |
Stage 3a | Subthreshold recurrence | 0 | 6 | 3 | 4 | 0 | 13 |
Stage 3b | Recurrence | 0 | 8 | 25 | 12 | 2 | 47 |
Stage 3c | Multiple recurrences | 0 | 56 | 348 | 433 | 80 | 917 |
<5 episodes | 0 | 19 | 114 | 70 | 13 | 216 | |
6‐10 episodes | 0 | 24 | 167 | 203 | 34 | 428 | |
> 10 episodes | 0 | 13 | 67 | 160 | 33 | 273 | |
Stage 4 | Unremitting illness | 0 | 3 | 16 | 0 | 0 | 19 |
Total | 0 | 73 | 396 | 451 | 82 | 1002 |
ρ: Spearman's rank correlation 0.21 (P < .05).